Optimally-Discriminative Voxel-Based Morphometry significantly increases the ability to detect group differences in schizophrenia, mild cognitive impairment, and Alzheimer's disease.
about
Diagnostic potential of structural neuroimaging for depression from a multi-ethnic community sample.Single subject prediction of brain disorders in neuroimaging: Promises and pitfalls.An efficient approach for differentiating Alzheimer's disease from normal elderly based on multicenter MRI using gray-level invariant features.Multimodal magnetic resonance imaging study of treatment-naïve adults with attention-deficit/hyperactivity disorder.White matter hyperintensities and imaging patterns of brain ageing in the general population.Heterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysis.Spatial patterns of structural brain changes in type 2 diabetic patients and their longitudinal progression with intensive control of blood glucose.Description and classification of normal and pathological aging processes based on brain magnetic resonance imaging morphology measures.Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings.Effects of Hormone Therapy on Brain Volumes Changes of Postmenopausal Women Revealed by Optimally-Discriminative Voxel-Based Morphometry.Anisotropic kernels for coordinate-based meta-analyses of neuroimaging studies.Multisite Machine Learning Analysis Provides a Robust Structural Imaging Signature of Schizophrenia Detectable Across Diverse Patient Populations and Within Individuals.Brainstem abnormalities in attention deficit hyperactivity disorder support high accuracy individual diagnostic classification.Association of white matter deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized VBM study using 3T.MIDAS: Regionally linear multivariate discriminative statistical mapping.
P2860
Q30490113-5F29EB4E-8D54-4457-B022-D49BC0189E04Q31063019-AD24BD9E-0DDE-4410-8E36-BAEF57C7B2B2Q34070840-FB20E125-729C-43C1-B436-9BEBACDF379AQ34332254-83243B6B-E02B-4E08-959B-401F6C7869ADQ34515561-DDD4304C-EF00-4C63-8974-1D0E6D217969Q34701102-BE1A2DEE-24D2-4361-B564-156F137672D4Q34762299-4EAA0798-809C-43E3-AAED-3680758ED131Q35774559-20D43827-8F69-40F2-8DFA-E8F70EC41689Q35889053-43501811-40F3-4A77-BAA8-C5269811CE0DQ36684570-62EECD23-FD65-4241-9ABA-2A1E5C594847Q41939091-16A85AD1-870B-474B-8AB3-0683BDB00EE9Q45943451-110BD33C-8A8D-487D-A676-55C241E06446Q45957118-C1D0A186-1DC1-4D99-846A-38B2E0771D68Q48953087-C6DC1387-ABC1-4649-8AA9-D317DD30838CQ50420063-BDF93BA3-26FA-4A04-91D5-42BC087D66CD
P2860
Optimally-Discriminative Voxel-Based Morphometry significantly increases the ability to detect group differences in schizophrenia, mild cognitive impairment, and Alzheimer's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Optimally-Discriminative Voxel ...... ment, and Alzheimer's disease.
@en
Optimally-Discriminative Voxel ...... ment, and Alzheimer's disease.
@nl
type
label
Optimally-Discriminative Voxel ...... ment, and Alzheimer's disease.
@en
Optimally-Discriminative Voxel ...... ment, and Alzheimer's disease.
@nl
prefLabel
Optimally-Discriminative Voxel ...... ment, and Alzheimer's disease.
@en
Optimally-Discriminative Voxel ...... ment, and Alzheimer's disease.
@nl
P2860
P1433
P1476
Optimally-Discriminative Voxel ...... ment, and Alzheimer's disease.
@en
P2093
Tianhao Zhang
P2860
P304
P356
10.1016/J.NEUROIMAGE.2013.04.063
P407
P577
2013-04-28T00:00:00Z